Follow
Caterina Marchi˛
Caterina Marchi˛
Verified email at unito.it
Title
Cited by
Cited by
Year
FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer
N Turner, A Pearson, R Sharpe, M Lambros, F Geyer, MA Lopez-Garcia, ...
Cancer research 70 (5), 2085-2094, 2010
7702010
Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients
DSP Tan, C Marchiˇ, RL Jones, K Savage, IE Smith, M Dowsett, ...
Breast cancer research and treatment 111, 27-44, 2008
4312008
Breast cancer precursors revisited: molecular features and progression pathways
MA Lopez‐Garcia, FC Geyer, M Lacroix‐Triki, C Marchiˇ, JS Reis‐Filho
Histopathology 57 (2), 171-192, 2010
3892010
ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research
C Marchi˛, M Scaltriti, M Ladanyi, AJ Iafrate, F Bibeau, M Dietel, ...
Annals of Oncology 30 (9), 1417-1427, 2019
2802019
Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray‐based CGH analysis
C Marchio, MB Lambros, P Gugliotta, LV Di Cantogno, C Botta, B Pasini, ...
The Journal of Pathology: A Journal of the Pathological Society of Greatá…, 2009
2202009
SF3B1 mutations constitute a novel therapeutic target in breast cancer
SL Maguire, A Leonidou, P Wai, C Marchi˛, CKY Ng, A Sapino, ...
The Journal of pathology 235 (4), 571-580, 2015
2152015
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands
I Weinreb, S Piscuoglio, LG Martelotto, D Waggott, CKY Ng, ...
Nature genetics 46 (11), 1166-1169, 2014
2042014
Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra‐tumour genetic heterogeneity and clonalá…
L Hernandez, PM Wilkerson, MB Lambros, A Campion‐Flora, ...
The Journal of pathology 227 (1), 42-52, 2012
1912012
Tiling path genomic profiling of grade 3 invasive ductal breast cancers
R Natrajan, MB Lambros, SM RodrÝguez-Pinilla, G Moreno-Bueno, ...
Clinical cancer research 15 (8), 2711-2722, 2009
1852009
Adenoid cystic carcinomas of the breast and salivary glands (or ‘The strange case of Dr Jekyll and Mr Hyde’of exocrine gland carcinomas)
C Marchio, B Weigelt, JS Reis-Filho
Journal of clinical pathology 63 (3), 220-228, 2010
1842010
Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines
E Arriola, C Marchio, DSP Tan, SC Drury, MB Lambros, R Natrajan, ...
Laboratory investigation 88 (5), 491-503, 2008
1802008
PPM1D is a potential therapeutic target in ovarian clear cell carcinomas
DSP Tan, MBK Lambros, S Rayter, R Natrajan, R Vatcheva, Q Gao, ...
Clinical cancer research 15 (7), 2269-2280, 2009
1772009
Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast
C Marchio, M Iravani, R Natrajan, MB Lambros, K Savage, N Tamber, ...
The Journal of pathology 215 (4), 398-410, 2008
1662008
Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants
F Pareja, FC Geyer, C Marchi˛, KA Burke, B Weigelt, JS Reis-Filho
NPJ breast cancer 2 (1), 1-11, 2016
1552016
Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis
MA Thorat, C Marchio, A Morimiya, K Savage, H Nakshatri, JS Reis-Filho, ...
Journal of clinical pathology 61 (3), 327-332, 2008
1482008
Neuroendocrine differentiation in breast cancer: established facts and unresolved problems
L Righi, A Sapino, C Marchi˛, M Papotti, G Bussolati
Seminars in diagnostic pathology 27 (1), 69-76, 2010
1342010
Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond
C Marchi˛, L Annaratone, A Marques, L Casorzo, E Berrino, A Sapino
Seminars in cancer biology 72, 123-135, 2021
1272021
Classification of pulmonary neuroendocrine tumors: new insights
G Pelosi, A Sonzogni, S Harari, A Albini, E Bresaola, C Marchi˛, F Massa, ...
Translational lung cancer research 6 (5), 513-529, 2017
1272017
Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT geneá…
S Piscuoglio, CKY Ng, M Murray, KA Burke, M Edelweiss, FC Geyer, ...
The Journal of pathology 238 (4), 508-518, 2016
1102016
ESR1 gene amplification in breast cancer: a common phenomenon?
JS Reis-Filho, S Drury, MB Lambros, C Marchio, N Johnson, R Natrajan, ...
Nature genetics 40 (7), 809-810, 2008
1072008
The system can't perform the operation now. Try again later.
Articles 1–20